Amphenol, Inc. (APH) Misses Q2 EPS by 5c; Guides Q3 Above the Street
Tweet
Share
E-mailGet Alerts APH Hot Sheet
Price: $82.78 +0.87%
EPS Growth %: -23.7%
Financial Fact:
Net income: 227.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -23.7%
Financial Fact:
Net income: 227.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amphenol, Inc. (NYSE: APH) reported Q2 EPS of $0.79, $0.05 worse than the analyst estimate of $0.84. Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.05 billion.
Sees Q3 sales of $1.08-$1.1 billion, which compares to the Street estimate of $1.06 billion. Sees EPS of 87-90c, vs. the consensus of 85c.
For earnings history and earnings-related data on Amphenol, Inc. (APH) click here.
Sees Q3 sales of $1.08-$1.1 billion, which compares to the Street estimate of $1.06 billion. Sees EPS of 87-90c, vs. the consensus of 85c.
For earnings history and earnings-related data on Amphenol, Inc. (APH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
